{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:40:52Z","timestamp":1792489252054,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:00:00Z","timestamp":1792454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R00CA256526"],"award-info":[{"award-number":["R00CA256526"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["P30CA033572"],"award-info":[{"award-number":["P30CA033572"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["AI171795"],"award-info":[{"award-number":["AI171795"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["BX005073"],"award-info":[{"award-number":["BX005073"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-77637-3","type":"journal-article","created":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:02:48Z","timestamp":1792486968000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Type I IFN promotes ILC2-to-ILC1 plasticity in pre-clinical radiation-induced lung injury"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7773-1747","authenticated-orcid":false,"given":"Jaeho","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5583-2240","authenticated-orcid":false,"given":"Haiqing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifat","family":"Mannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor A.","family":"Doherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3761-5087","authenticated-orcid":false,"given":"Heather M.","family":"McGee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,20]]},"reference":[{"key":"77637_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"Cancer J. Clin."},{"key":"77637_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.radonc.2015.04.021","volume":"116","author":"JM Borras","year":"2015","unstructured":"Borras, J. M. et al. The impact of cancer incidence and stage on optimal utilization of radiotherapy: Methodology of a population based analysis by the ESTRO-HERO project. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 116, 45\u201350 (2015).","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"77637_CR3","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ijrobp.2023.10.044","volume":"118","author":"ME Kuipers","year":"2024","unstructured":"Kuipers, M. E., van Doorn-Wink, K. C. J., Hiemstra, P. S. & Slats, A. M. Predicting radiation-induced lung injury in patients with lung cancer: challenges and opportunities. Int. J. Radiat. Oncol. Biol. Phys. 118, 639\u2013649 (2024).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"77637_CR4","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.chest.2019.03.033","volume":"156","author":"AN Hanania","year":"2019","unstructured":"Hanania, A. N., Mainwaring, W., Ghebre, Y. T., Hanania, N. A. & Ludwig, M. Radiation-induced lung injury: assessment and management. Chest 156, 150\u2013162 (2019).","journal-title":"Chest"},{"key":"77637_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.radonc.2015.09.001","volume":"117","author":"N Ebert","year":"2015","unstructured":"Ebert, N., Baumann, M. & Troost, E. G. Radiation-induced lung damage - Clinical risk profiles and predictive imaging on their way to risk-adapted individualized treatment planning?. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 117, 1\u20133 (2015).","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"77637_CR6","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1200\/JCO.2009.26.2543","volume":"28","author":"A Auperin","year":"2010","unstructured":"Auperin, A. et al. Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 28, 2181\u20132190 (2010).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"77637_CR7","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","volume":"16","author":"JY Chang","year":"2015","unstructured":"Chang, J. Y. et al. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.  Lancet Oncol. 16, 630\u2013637 (2015).","journal-title":"Lancet Oncol."},{"key":"77637_CR8","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1200\/JCO.20.00818","volume":"38","author":"DA Palma","year":"2020","unstructured":"Palma, D. A. et al. Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial. J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 38, 2830\u20132838 (2020).","journal-title":"J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol."},{"key":"77637_CR9","doi-asserted-by":"publisher","first-page":"708","DOI":"10.4329\/wjr.v6.i9.708","volume":"6","author":"H Yamashita","year":"2014","unstructured":"Yamashita, H., Takahashi, W., Haga, A. & Nakagawa, K. Radiation pneumonitis after stereotactic radiation therapy for lung cancer. World J. Radiol. 6, 708\u2013715 (2014).","journal-title":"World J. Radiol."},{"key":"77637_CR10","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1748-717X-2-21","volume":"2","author":"H Yamashita","year":"2007","unstructured":"Yamashita, H. et al. Exceptionally high incidence of symptomatic grade 2-5 radiation pneumonitis after stereotactic radiation therapy for lung tumors. Radiat. Oncol. 2, 21 (2007).","journal-title":"Radiat. Oncol."},{"key":"77637_CR11","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1097\/01243894-200610000-00008","volume":"1","author":"QT Le","year":"2006","unstructured":"Le, Q. T. et al. Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. J. Thorac. Oncol. 1, 802\u2013809 (2006).","journal-title":"J. Thorac. Oncol."},{"key":"77637_CR12","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.radonc.2020.12.015","volume":"156","author":"A Saha","year":"2021","unstructured":"Saha, A. et al. Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK\u2019s largest cohort of lung SABR patients. Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol. 156, 153\u2013159 (2021).","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther. Radiol. Oncol."},{"key":"77637_CR13","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3389\/fimmu.2016.00591","volume":"7","author":"F Wirsdorfer","year":"2016","unstructured":"Wirsdorfer, F. & Jendrossek, V. The role of lymphocytes in radiotherapy-induced adverse late effects in the lung. Front Immunol. 7, 591 (2016).","journal-title":"Front Immunol."},{"key":"77637_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2024.105089","volume":"103","author":"M Fijardo","year":"2024","unstructured":"Fijardo, M. et al. The clinical manifestations and molecular pathogenesis of radiation fibrosis. EBioMedicine 103, 105089 (2024).","journal-title":"EBioMedicine"},{"key":"77637_CR15","doi-asserted-by":"publisher","first-page":"877","DOI":"10.3389\/fonc.2019.00877","volume":"9","author":"L Giuranno","year":"2019","unstructured":"Giuranno, L., Ient, J., De Ruysscher, D. & Vooijs, M. A. Radiation-induced lung injury (RILI). Front. Oncol. 9, 877 (2019).","journal-title":"Front. Oncol."},{"key":"77637_CR16","doi-asserted-by":"publisher","first-page":"3010","DOI":"10.21037\/tlcr-24-649","volume":"13","author":"X Ge","year":"2024","unstructured":"Ge, X. et al. STING facilitates the development of radiation-induced lung injury via regulating the PERK\/eIF2\u03b1 pathway. Transl. Lung Cancer Res. 13, 3010\u20133025 (2024).","journal-title":"Transl. Lung Cancer Res."},{"key":"77637_CR17","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00432-025-06088-y","volume":"151","author":"X Zhao","year":"2025","unstructured":"Zhao, X. et al. The role of cGAS-STING pathway in the development of radiation-induced lung injury. J. Cancer Res. Clin. Oncol. 151, 48 (2025).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"77637_CR18","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.3390\/cancers12061561","volume":"12","author":"H Jin","year":"2020","unstructured":"Jin, H. et al. Radiation-induced lung fibrosis: preclinical animal models and therapeutic strategies. Cancers 12, 1561 (2020).","journal-title":"Cancers"},{"key":"77637_CR19","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1084\/jem.20162152","volume":"214","author":"AV Misharin","year":"2017","unstructured":"Misharin, A. V. et al. Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span. J. Exp. Med. 214, 2387\u20132404 (2017).","journal-title":"J. Exp. Med."},{"key":"77637_CR20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1007\/s00109-010-0622-5","volume":"88","author":"S Park","year":"2010","unstructured":"Park, S. et al. Sustained expression of NADPH oxidase 4 by p38 MAPK-Akt signaling potentiates radiation-induced differentiation of lung fibroblasts. J. Mol. Med. 88, 807\u2013816 (2010).","journal-title":"J. Mol. Med."},{"key":"77637_CR21","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/ni.2131","volume":"12","author":"LA Monticelli","year":"2011","unstructured":"Monticelli, L. A. et al. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12, 1045\u20131054 (2011).","journal-title":"Nat. Immunol."},{"key":"77637_CR22","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1073\/pnas.1315854111","volume":"111","author":"E Hams","year":"2014","unstructured":"Hams, E. et al. IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis. Proc. Natl. Acad. Sci. USA 111, 367\u2013372 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77637_CR23","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ado6649","volume":"17","author":"X Ju","year":"2025","unstructured":"Ju, X. et al. A population of c-kit(+) IL-17A(+) ILC2s in sputum from individuals with severe asthma supports ILC2 to ILC3 trans-differentiation. Sci. Transl. Med. 17, eado6649 (2025).","journal-title":"Sci. Transl. Med."},{"key":"77637_CR24","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/nri3365","volume":"13","author":"H Spits","year":"2013","unstructured":"Spits, H. et al. Innate lymphoid cells\u2013a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145\u2013149 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"77637_CR25","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.immuni.2018.05.013","volume":"48","author":"M Colonna","year":"2018","unstructured":"Colonna, M. Innate Lymphoid Cells: Diversity, Plasticity, and Unique Functions in Immunity. Immunity 48, 1104\u20131117 (2018).","journal-title":"Immunity"},{"key":"77637_CR26","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/nri.2017.86","volume":"17","author":"M Ebbo","year":"2017","unstructured":"Ebbo, M., Crinier, A., Vely, F. & Vivier, E. Innate lymphoid cells: major players in inflammatory diseases. Nat. Rev. Immunol. 17, 665\u2013678 (2017).","journal-title":"Nat. Rev. Immunol."},{"key":"77637_CR27","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/eji.201142018","volume":"42","author":"RG Klein Wolterink","year":"2012","unstructured":"Klein Wolterink, R. G. et al. Pulmonary innate lymphoid cells are major producers of IL-5 and IL-13 in murine models of allergic asthma. Eur. J. Immunol. 42, 1106\u20131116 (2012).","journal-title":"Eur. J. Immunol."},{"key":"77637_CR28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3389\/fimmu.2020.00691","volume":"11","author":"A Schulz-Kuhnt","year":"2020","unstructured":"Schulz-Kuhnt, A. et al. ILC2 Lung-homing in cystic fibrosis patients: functional involvement of CCR6 and impact on respiratory failure. Front. Immunol. 11, 691 (2020).","journal-title":"Front. Immunol."},{"key":"77637_CR29","doi-asserted-by":"publisher","first-page":"92","DOI":"10.3389\/fimmu.2019.00092","volume":"10","author":"A Ardain","year":"2019","unstructured":"Ardain, A., Porterfield, J. Z., Kloverpris, H. N. & Leslie, A. Type 3 ILCs in lung disease. Front. Immunol. 10, 92 (2019).","journal-title":"Front. Immunol."},{"key":"77637_CR30","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1038\/s41577-020-0282-9","volume":"20","author":"SM Bal","year":"2020","unstructured":"Bal, S. M., Golebski, K. & Spits, H. Plasticity of innate lymphoid cell subsets. Nat. Rev. Immunol. 20, 552\u2013565 (2020).","journal-title":"Nat. Rev. Immunol."},{"key":"77637_CR31","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.immuni.2015.06.019","volume":"43","author":"JH Bernink","year":"2015","unstructured":"Bernink, J. H. et al. Interleukin-12 and \u221223 control plasticity of CD127(+) group 1 and group 3 innate lymphoid cells in the intestinal lamina propria. Immunity 43, 146\u2013160 (2015).","journal-title":"Immunity"},{"key":"77637_CR32","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1084\/jem.20151750","volume":"213","author":"AI Lim","year":"2016","unstructured":"Lim, A. I. et al. IL-12 drives functional plasticity of human group 2 innate lymphoid cells.  J. Exp. Med. 213, 569\u2013583 (2016).","journal-title":"J. Exp. Med."},{"key":"77637_CR33","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1038\/ni.3443","volume":"17","author":"JS Silver","year":"2016","unstructured":"Silver, J. S. et al. Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs. Nat. Immunol. 17, 626\u2013635 (2016).","journal-title":"Nat. Immunol."},{"key":"77637_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.618807","volume":"12","author":"KJ Cavagnero","year":"2021","unstructured":"Cavagnero, K. J. et al. Cyclic-di-GMP Induces STING-Dependent ILC2 to ILC1 Shift During Innate Type 2 Lung Inflammation. Front. Immunol. 12, 618807 (2021).","journal-title":"Front. Immunol."},{"key":"77637_CR35","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.jaci.2020.05.042","volume":"146","author":"KJ Cavagnero","year":"2020","unstructured":"Cavagnero, K. J. & Doherty, T. A. ILC2s: Are they what we think they are?. J. Allergy Clin. Immunol. 146, 280\u2013282 (2020).","journal-title":"J. Allergy Clin. Immunol."},{"key":"77637_CR36","doi-asserted-by":"publisher","unstructured":"Leibowitz B. J. et al. Interferon \u03b2 drives intestinal regeneration after radiation. Sci. Adv. 7 https:\/\/doi.org\/10.1126\/sciadv.abi5253 (2021).","DOI":"10.1126\/sciadv.abi5253"},{"key":"77637_CR37","doi-asserted-by":"publisher","unstructured":"Cinat D. et al. IFN-I signaling enhances salivary gland stem and progenitor cell activity after irradiation. Sci. Signal 18, https:\/\/doi.org\/10.1126\/scisignal.ady0398 (2025).","DOI":"10.1126\/scisignal.ady0398"},{"key":"77637_CR38","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.ijrobp.2018.11.038","volume":"103","author":"JC Fischer","year":"2019","unstructured":"Fischer, J. C. et al. Regeneration after radiation- and immune-mediated tissue injury is not enhanced by type III interferon signaling. Int. J. Radiat. Oncol. Biol. Phys. 103, 970\u2013976 (2019).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"77637_CR39","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s13046-021-01962-2","volume":"40","author":"RSA Goedegebuure","year":"2021","unstructured":"Goedegebuure, R. S. A. et al. Interferon- and STING-independent induction of type I interferon stimulated genes during fractionated irradiation. J. Exp. Clin. Cancer Res. 40, 161 (2021).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"77637_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/nri3787","volume":"15","author":"F McNab","year":"2015","unstructured":"McNab, F., Mayer-Barber, K., Sher, A., Wack, A. & O\u2019Garra, A. Type I interferons in infectious disease. Nat. Rev. Immunol. 15, 87\u2013103 (2015).","journal-title":"Nat. Rev. Immunol."},{"key":"77637_CR41","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.add7446","volume":"8","author":"S Tadepalli","year":"2023","unstructured":"Tadepalli, S. et al. Rapid recruitment and IFN-I-mediated activation of monocytes dictate focal radiotherapy efficacy. Sci. Immunol. 8, eadd7446 (2023).","journal-title":"Sci. Immunol."},{"key":"77637_CR42","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/ni.3308","volume":"17","author":"CU Duerr","year":"2016","unstructured":"Duerr, C. U. et al. Type I interferon restricts type 2 immunopathology through the regulation of group 2 innate lymphoid cells. Nat. Immunol. 17, 65\u201375 (2016).","journal-title":"Nat. Immunol."},{"key":"77637_CR43","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/ni.3078","volume":"16","author":"Y Huang","year":"2015","unstructured":"Huang, Y. et al. IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential \u2018inflammatory\u2019 type 2 innate lymphoid cells. Nat. Immunol. 16, 161\u2013169 (2015).","journal-title":"Nat. Immunol."},{"key":"77637_CR44","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1056\/NEJMoa1912196","volume":"382","author":"EF Morand","year":"2020","unstructured":"Morand, E. F. et al. Trial of Anifrolumab in Active Systemic Lupus Erythematosus. N. Engl. J. Med. 382, 211\u2013221 (2020).","journal-title":"N. Engl. J. Med."},{"key":"77637_CR45","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1073\/pnas.0337679100","volume":"100","author":"EC Baechler","year":"2003","unstructured":"Baechler, E. C. et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl. Acad. Sci. USA 100, 2610\u20132615 (2003).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"77637_CR46","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.radonc.2017.10.002","volume":"125","author":"K Diao","year":"2017","unstructured":"Diao, K. et al. Radiation toxicity in patients with collagen vascular disease and intrathoracic malignancy treated with modern radiation techniques. Radiother. Oncol. J. Eur. Soc. Ther Radiol. Oncol. 125, 301\u2013309 (2017).","journal-title":"Radiother. Oncol. J. Eur. Soc. Ther Radiol. Oncol."},{"key":"77637_CR47","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00408-015-9825-4","volume":"194","author":"Z-Y Hong","year":"2016","unstructured":"Hong, Z.-Y. et al. Time, dose, and volume responses in a mouse pulmonary injury model following ablative irradiation. Lung 194, 81\u201390 (2016).","journal-title":"Lung"},{"key":"77637_CR48","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.ijrobp.2009.12.074","volume":"77","author":"J Cho","year":"2010","unstructured":"Cho, J. et al. High dose\u2013per-fraction irradiation of limited lung volumes using an image-guided, highly focused irradiator: simulating stereotactic body radiotherapy regimens in a small-animal model. Int. J. Radiat. Oncol. Biol. Phys. 77, 895\u2013902 (2010).","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"77637_CR49","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1084\/jem.20101158","volume":"208","author":"MS Diamond","year":"2011","unstructured":"Diamond, M. S. et al. Type I interferon is selectively required by dendritic cells for immune rejection of tumors.  J. Exp. Med. 208, 1989\u20132003 (2011).","journal-title":"J. Exp. Med."},{"key":"77637_CR50","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41416-018-0352-y","volume":"120","author":"H Ma","year":"2019","unstructured":"Ma, H. et al. Interferon-alpha promotes immunosuppression through IFNAR1\/STAT1 signalling in head and neck squamous cell carcinoma. Br. J. Cancer 120, 317\u2013330 (2019).","journal-title":"Br. J. Cancer"},{"key":"77637_CR51","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell, C. et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat. Biotechnol. 32, 381\u2013386 (2014).","journal-title":"Nat. Biotechnol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77637-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77637-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77637-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:02:50Z","timestamp":1792486970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-77637-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,20]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["77637"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-77637-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,20]]},"assertion":[{"value":"12 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10611"}}